Axa
MTEM

Axa’s Molecular Templates, Inc. MTEM Stock Holding History

Axa’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,367
Closed -$160K – 1346
2021
Q2 		$160K Sell
1,367
-4,540
-77% -$594K ﹤0.01% 1230
2021
Q1 		$1.12M Buy
+5,907
New +$1.04M ﹤0.01% 958
2020
Q1 		– Sell
-17,589
Closed -$3.69M – 1267
2019
Q4 		$3.69M Sell
17,589
-26,776
-60% -$3.85M 0.02% 697
2019
Q3 		$4.39M Buy
44,365
+3,467
+8% +$323K 0.02% 692
2019
Q2 		$5.12M Buy
40,898
+898
+2% +$97.6K 0.02% 650
2019
Q1 		$3.49M Hold
40,000
– – 0.01% 737
2018
Q4 		$2.42M Hold
40,000
– – 0.01% 781
2018
Q3 		$3.23M Buy
+40,000
New +$3.07M 0.01% 779
2015
Q4 		– Sell
-10,729
Closed -$7.21M – 1513
2015
Q3 		$7.21M Buy
10,729
+1,539
+17% +$1.09M 0.03% 464
2015
Q2 		$6.13M Buy
9,190
+1,124
+14% +$743K 0.02% 544
2015
Q1 		$5.4M Buy
8,066
+1,993
+33% +$1.31M 0.02% 574
2014
Q4 		$3.19M Buy
6,073
+2,524
+71% +$1.26M 0.01% 677
2014
Q3 		$2.11M Sell
3,549
-22
-0.6% -$15.2K 0.01% 735
2014
Q2 		$2.33M Sell
3,571
-144
-4% -$95.4K 0.01% 736
2014
Q1 		$2.92M Buy
3,715
+193
+5% +$157K 0.01% 664
2013
Q4 		$2.71M Buy
3,522
+1,988
+130% +$1.5M 0.01% 693
2013
Q3 		$1.18M Buy
1,534
+350
+30% +$288K 0.01% 841
2013
Q2 		$1.03M Buy
+1,184
New +$1M 0.01% 832

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Axa's MTEM Position: Q3 2021 in Review

Axa sold out of Molecular Templates, Inc. (MTEM) in Q3 2021, closing a stake of 1,367 shares — an estimated $160K sold.

Axa first reported a position in MTEM in Q2 2013 and held it in 18 quarters. The position peaked at $7.21M in Q3 2015. 86 funds tracked by Wall St. Rank hold MTEM as of Q3 2021.

  • Axa reported no remaining Molecular Templates, Inc. position as of Q3 2021 after selling out during the quarter.
  • Axa sold 1,367 Molecular Templates, Inc. shares in Q3 2021, an estimated $160K.
  • Axa first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 18 quarters.
  • Axa's Molecular Templates, Inc. position peaked at $7.21M in Q3 2015.
  • 86 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.